Showing results (391-400 of 418) with videos related to

Sort By:
Pageof 42
European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapyMarco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens, et al.
European Urology Focus|September 10, 2019
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen DeprivationStephanie G C Kroeze, Christoph Henkenberens, Nina Sophie Schmidt-Hegemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 1, 2020
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective studyN-S Schmidt-Hegemann, S G C Kroeze, C Henkenberens, et al.
Cell Death and Differentiation|May 18, 2023
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancerCarina R Maier, Oliver Hartmann, Cristian Prieto-Garcia, et al.
Nature Metabolism|January 20, 2025
Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulationMarteinn T Snaebjornsson, Philipp Poeller, Daria Komkova, et al.
Frontiers in Oncology|May 27, 2021
Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter StudySimon Kirste, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
BMC Cancer|May 1, 2020
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapyAnn-Kathrin Oehus, Stephanie G C Kroeze, Nina-Sophie Schmidt-Hegemann, et al.
Biotechnology Journal|May 8, 2024
Generation of stable suspension producer cell lines for serum-free lentivirus productionMaximilian Klimpel, Monica Terrao, Melina Bräuer, et al.
JCO Precision Oncology|September 11, 2020
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Kilian Wistuba-Hamprecht, Teofila Seremet, et al.
Pageof 42